Loading...

BioMark Diagnostics Inc.

BMKDF•PNK
Healthcare
Medical - Diagnostics & Research
$0.41
$-0.00(-0.91%)
U.S. Market is Open • 11:51

BioMark Diagnostics Inc. (BMKDF) Stock Overview

Explore BioMark Diagnostics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap44.5M
P/E Ratio-35.90
EPS (TTM)$-0.01
ROE-1.53%
Fundamental Analysis

AI Price Forecasts

1 Month$0.43
3 Months$0.48
1 Year Target$0.41

BMKDF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioMark Diagnostics Inc. (BMKDF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.90 and a market capitalization of 44.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.22%
5-Day Change
1.22%
1-Month Change
-0.98%
3-Month Change
15.99%
6-Month Change
76.58%
Year-to-Date (YTD) Change
23.59%
1-Year Change
135.44%
3-Year Change
145.31%
5-Year Change
-4.76%
All-Time (Max) Change
22.84%

Contact Information

https://www.biomarkdiagnostics.com
604 370 0779
3851 Shell Road, Richmond, BC, V6X 2W2

Company Facts

9 Employees
IPO DateMar 23, 2015
CountryCA
Actively Trading

Frequently Asked Questions